Cargando…

Implantable Cardioverter-Defibrillators in Poland Compared with other European Countries from the Patient’s Perspective: Insights from the EHRA Patient Survey

Background: The aim of this study was to compare differences between Polish ICD recipients and ICD recipients from other European countries in terms of quality of life, information provision before ICD implantation, and end-of-life issues. Methods: This is a sub-analysis of the “Living with an ICD”...

Descripción completa

Detalles Bibliográficos
Autores principales:	Januszkiewicz, Łukasz, Grabowski, Marcin, Farkowski, Michał Mirosław, Życiński, Paweł, Jędrychowski, Tomasz, Pytkowski, Mariusz, Chun, Julian K. R., Guerra, Jose M., Conte, Giulio, Barra, Sérgio, Boveda, Serge, Kempa, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049532/ https://www.ncbi.nlm.nih.gov/pubmed/36981953 http://dx.doi.org/10.3390/ijerph20065045

Ejemplares similares

Regional disparity on patient characteristics and perceptions after implantable cardioverter-defibrillator implantation: results from an EHRA patient survey
por: Januszkiewicz, Łukasz, et al.
Publicado: (2023)

Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation
por: Januszkiewicz, Łukasz, et al.
Publicado: (2023)

Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland
por: Kaczmarek, Krzysztof, et al.
Publicado: (2019)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
por: Kempa, Maciej, et al.
Publicado: (2021)

Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
por: Schwab, Ana Carolina, et al.
Publicado: (2022)

Conduction system pacing in everyday clinical practice: EHRA physician survey
por: Kircanski, Bratislav, et al.
Publicado: (2022)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing()()
por: Wilkoff, Bruce L., et al.
Publicado: (2016)

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey
por: Adeliño, Raquel, et al.
Publicado: (2023)

Don’t lose the ground—the EHRA blanking period survey
por: Bordignon, Stefano, et al.
Publicado: (2023)

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland
por: Kempa, Maciej, et al.
Publicado: (2023)

2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
por: Stiles, Martin K., et al.
Publicado: (2020)

Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey
por: Iliodromitis, Konstantinos, et al.
Publicado: (2022)

Electrophysiology fellowship experience and requirements: an EHRA survey
por: Linz, Dominik, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center
por: Grabowski, Marcin, et al.
Publicado: (2019)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
por: Galand, Vincent, et al.
Publicado: (2021)

Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey
por: Baldi, Enrico, et al.
Publicado: (2022)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Erratum to ‘2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-deﬁbrillator programming and testing’ [Journal of Arrhythmia 32/1 (2016) 1–28]
por: Wilkoff, Bruce L., et al.
Publicado: (2016)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry
por: Providência, Rui, et al.
Publicado: (2016)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Do elderly patients benefit from implantable-cardioverter defibrillators?
por: de Groot, J. R.
Publicado: (2014)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry
por: van Rosmalen, Frank, et al.
Publicado: (2020)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation -- a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)
por: Farkowski, Michal M, et al.
Publicado: (2012)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience
por: Wieniawski, Piotr, et al.
Publicado: (2022)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ske7r7h0nnjv41su7gbe89mpbk